(Q37272623)

19 August 2017

1 reference

title

EGFR family: structure physiology signalling and therapeutic targets (English)

1 reference

19 August 2017

0 references

Antony W Burgess

1

1 reference

PubMed ID

18800267

19 August 2017

language of work or name

1 reference

1 October 2008

1 reference

19 August 2017

Growth Factors Journal

1 reference

19 August 2017

26

1 reference

19 August 2017

263-274

1 reference

19 August 2017

5

1 reference

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer--a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

EGF receptor mutations in lung cancer: from humans to mice and maybe back to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB receptors in fetal endothelium--a potential linkage point for inflammation-associated neonatal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

PET imaging of acute and chronic inflammation in living mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB-4: mechanism of action and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Nuclear localization and possible functions of receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Tackling the EGFR in pathological tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Phase II randomized study of daily gefitinib treatment alone or with vinorelbine every 2 weeks in patients with adenocarcinoma of the lung who failed at least 2 regimens of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Structure of the extracellular region of HER3 reveals an interdomain tether

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ERBB4/HER4 potentiates STAT5A transcriptional activity by regulating novel STAT5A serine phosphorylation events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Unligated epidermal growth factor receptor forms higher order oligomers within microclusters on A431 cells that are sensitive to tyrosine kinase inhibitor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The role of the ErbB family members in non-small cell lung cancers sensitive to epidermal growth factor receptor kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The discovery of receptor tyrosine kinases: targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB receptors: directing key signaling networks throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Targeting ADAMS and ERBBs in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Epidermal growth factor receptor: mechanisms of activation and signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Breast cancer: the upgraded role of HER-3 and HER-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Targeting TACE-dependent EGFR ligand shedding in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Expression of ErbB receptors during pancreatic islet development and regrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Cloning and sequence analysis of a cDNA for rat transforming growth factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Requirement for neuregulin receptor erbB2 in neural and cardiac development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

EGF receptor as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Tyrphostins and other tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Therapeutic anti-EGFR antibody 806 generates responses in murine de novo EGFR mutant-dependent lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Mice with a null mutation of the TGF alpha gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Cetuximab in the treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Essential roles of Her2/erbB2 in cardiac development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Molecular mechanisms of epidermal growth factor receptor (EGFR) activation and response to gefitinib and other EGFR-targeting drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

EGFR signaling leads to downregulation of PTP-LAR via TACE-mediated proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Are exon 19 deletions and L858R EGFR mutations in non-small-cell lung cancer clinically different?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Flat revertants derived from kirsten murine sarcoma virus-transformed cells produce transforming growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The epidermal growth factor receptor pathway: a model for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Constitutive activation of neuregulin/ERBB3 signaling pathway in clear cell sarcoma of soft tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Distinct ADAM metalloproteinases regulate G protein-coupled receptor-induced cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The proliferative and morphologic responses of a colon carcinoma cell line (LIM 1215) require the production of two autocrine factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Herceptin: increasing survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The FUTURE of ErbB-1 and ErbB-2 pathway inhibition in breast cancer: targeting multiple receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Phenotypic variation resulting from a deficiency of epidermal growth factor receptor in mice is caused by extensive genetic heterogeneity that can be genetically and molecularly partitioned

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Single-molecule analysis of epidermal growth factor binding on the surface of living cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Identification of a novel EGF-sensitive cell cycle checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Signaling through ERBB receptors: multiple layers of diversity and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Heregulin-dependent translocation and hyperphosphorylation of ErbB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Strain-dependent epithelial defects in mice lacking the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

Effect of Epidermal Growth Factor Receptor Inhibitor Class in the Treatment of Head and Neck Cancer with Concurrent Radiochemotherapy In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08977190802312844

10.1080/08977190802312844

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18800267